Viking Therapeutics Inc (NASDAQ:VKTX)
| 11.74 Delayed Data As of Nov 28 |  -0.28 / -2.33%Today’s Change | 3.54 Today|||52-Week Range 25.72 | +24.84% Year-to-Date |
Latest VKTX News | Press Releases
No recent news for Viking Therapeutics Inc.
Today’s Trading
| Previous close | 12.00 |
| Today’s open | 11.94 |
| Day’s range | 11.55 - 12.07 |
| Volume | 813,926 |
| Average volume (3 months) | 1,893,711 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -25.83% |
| Earnings growth (this year) | +5.86% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.55 |
Competitors
| ---- | ||
| AGIOAgios Pharmaceutical... | +0.52 | +2.40% |
| OPKOPKO Health Inc | -0.01 | -0.64% |
| PCRXPacira Biosciences I... | +1.18 | +4.48% |
Data as of 3:59pm ET, 11/28/2023
Financials
| Next reporting date | February 7, 2024 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$68.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
